Quarterly ResultsRevenues for the third quarter were $6.3 million versus $7.5 million for the third quarter of 2012. The decrease in revenues was the result of lower product and contract revenues. Although eMagin sold a similar number of displays in the third quarter of 2013 as compared to 2012, the different mix of products resulted in a decrease in product revenue for the quarter. With respect to contract revenue, eMagin had two active contracts for the three and nine months ended September 30, 2013, compared to 10 and 11 active contracts, respectively, for the three and nine months ended September 30, 2012. As noted above, the Company believes that fewer R&D contracts are being awarded this year by U.S. government agencies, which are the main source of most of the Company’s R&D contracts historically, due to the U.S. government sequestration and budget issues. Gross margin for the third quarter was 35 percent on gross profit of $2.2 million compared to a gross margin of 49 percent in the same quarter last year and gross margin of 34 percent in the second quarter of 2013. The lower gross margin is due to a lower average price, higher material and labor costs, and also due to concurrently running both deposition tools this year compared to only the Satella deposition tool in the first nine months of 2012. Operating expenses are comprised of R&D expenses and selling, general and administrative (SG&A) expenses. SG&A expense increased approximately $123,000 and R&D expenses increased approximately $66,000 from the same quarter last year. Year to date, operating expenses increased just 1%. The increase in R&D expense was due primarily to an increase in internal research and development costs. The increase in SG&A expenses for the three-month period was related to an increase in related personnel costs offset by reduced professional fees.
Pretax net loss for the third quarter of 2013 was $1,057,000 compared to pretax net income of $561,000 for the third quarter of 2012. In the third quarter, the Company adjusted its deferred tax asset valuation allowance by approximately $3.5 million, resulting in a $3,502,000 provision for income taxes and $4,559,000 in net loss after tax or ($0.19) per share compared to $0.01 per share in Q3 last year. Adjusted EBITDA for the third quarter was a loss of $247,000.At September 30, 2013, the Company continued to have no debt and had approximately $13.1 million of cash, cash equivalents, and investments in certificates of deposit and corporate bonds, compared to $13.4 million at December 31, 2012. Recent Corporate Highlights
- Started delivering displays for a new weapons sight program.
- Continued shipping significant quantities of Display Beam Combiner Assemblies (DBCAs), which consist of the Company’s SVGA display combined with an optic. Because of their higher level of integration, DBCAs have a higher sales price than a display alone. These DBCAs were delivered to eMagin’s customer, Exelis. Exelis was also awarded funding for the 3rd year of production for ENVG II. eMagin expects DBCA deliveries to continue well into 2014.
- Hired Robert J. Kaizerman as VP Manufacturing, reporting to Andrew Sculley, President and CEO. Mr. Kaizerman brings more than 25 years of high tech manufacturing and operational experience to eMagin, including Elbit Systems of America, Schott Corporation, Luminus Devices Incorporated and GSI Lumonics Incorporated.
- The DSVGA, our new digital SVGA display, is currently undergoing qualification testing and is expected to be released for production by the end of the year. This will provide our customers all of the advantages of our latest technology in a digital display. Orders can be accepted now for deliveries beginning in late January 2014.
- The SXGA096, our new smaller pixel size SXGA display, is being redesigned to a new form factor and engineering samples are scheduled for availability in March 2014, with production release scheduled for May 2014. This display will provide our customers the high resolution of a SXGA display but with a smaller form factor and lower cost of production than larger pixel SXGA displays.
- The SXGA096 redesign was postponed to accommodate design of a new custom microdisplay development aimed at a new ultra high brightness market. This effort is currently on schedule and expected to delivery prototypes by year’s end.
- We continue work on a color, high brightness, high-resolution avionics display with funding from the US Navy. We expect to demonstrate the direct patterned ultra-high brightness display in the first quarter of 2014 and perform customer evaluations in Q2 2014.
- We have an opportunity for a viewfinder application for our new XGA display with a large camera manufacturer in 2014.
- We expect to demonstrate a direct patterned ultra-high brightness display in the first quarter of 2014 and perform customer evaluations in the second quarter 2014.
- As showcased at this year's Society of Information Display conference, eMagin's Color OLED-XLS TM technology provides the highest OLED microdisplay luminance on the market. XLS provides up to 1,000 nits in full color while maintaining a 10,000:1 contrast ratio. This level of performance allows our customers to use our displays in "see-through" Augmented Reality applications, work effectively with wide field of view optics for entertainment and training and simulation and multispectral fused systems for the military. The Color OLED-XLS TM is fully compatible with eMagin's entire VGA, SVGA, XGA, SXGA and WUXGA product line and will be available on our products by the first quarter of 2014.
- Continued to ship displays for the FELIN Soldier Modernization Program in France, to BAE/Oasys, to FLIR in Sweden for three industrial thermal camera EVFs, and to BCF Technology in Scotland for the BUG Binocular Ultrasound Goggles among others.
Conference Call InformationFull results will be published in the Company's 10-Q report for the third quarter ended September 30, 2013, expected to be filed with the Securities and Exchange Commission on or before November 15, 2013, and will also be available via the Company’s website, www.emagin.com. A conference call and live webcast will begin today at 4:45 p.m. ET. An archive of the webcast will be available one hour after the live call through December 12, 2013. To access the live Webcast or archive, please visit the Company's website at ir.emagin.com or www.earnings.com. About eMagin Corporation A leader in OLED microdisplay technology, OLED microdisplay manufacturing know-how and mobile display systems, eMagin manufactures high-resolution OLED microdisplays and integrates them with magnifying optics to deliver virtual images comparable to large-screen computer and television displays in portable, low-power, lightweight personal displays. eMagin microdisplays provide near-eye imagery in a variety of products from military, industrial, medical and consumer OEMs. More information about eMagin is available at www.emagin.com. Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including those regarding eMagin Corporation's expectations, intentions, strategies and beliefs pertaining to future events or future financial performance. Actual events or results may differ materially from those in the forward-looking statements as a result of various important factors, including those described in the Company's most recent filings with the Securities and Exchange Commission, including the Company’s reports on Form 10-K, Form 10-Q and Form 8-K. For example, factors that could cause actual results to vary materially from future results include, but are not limited to: our ability to successfully develop and market our products to customers; our ability to generate customer demand for our products in our target markets; the development of our target markets and market opportunities; our ability to manufacture suitable products at competitive cost; our ability to successfully launch new equipment on our manufacturing line; market pricing for our products and for competing products; the extent of increasing competition; technological developments in our target markets and the development of alternate, competing technologies in them; and sales of shares by existing shareholders. Although management believes that the expectations reflected in the forward-looking statements are reasonable, such statements should not be regarded as a representation by the Company, the directors or officers of the Company, or any other person, that such forward-looking statements will be achieved. The business and operations of the Company are subject to substantial risks and changes in facts and circumstances which increase the uncertainty inherent in forward-looking statements. The Company undertakes no duty to update any of the forward-looking statements, whether as a result of new information, future events or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such forward-looking statements.
Non-GAAP Financial MeasuresTo supplement the Company's consolidated financial statements presented on a GAAP basis, the Company has provided non-GAAP financial information, namely earnings before interest, taxes, depreciation and amortization (EBITDA). The Company's management believes that this non-GAAP measure provides investors with a better understanding of how the results relate to the Company's historical performance. The additional adjusted information is not meant to be considered in isolation or as a substitute for GAAP financials. Management believes that these adjusted measures reflect the essential operating activities of the Company. A reconciliation of non-GAAP financial information appears below:
|eMAGIN CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands, except share data)|
|September 30, 2013||December 31,|
|Cash and cash equivalents||$||4,811||$||4,385|
|Accounts receivable, net||3,850||5,154|
|Prepaid expenses and other current assets||1,314||653|
|Total current assets||22,382||21,935|
|Equipment, furniture and leasehold improvements, net||8,197||8,099|
|Deferred tax asset||5,382||8,881|
|LIABILITIES AND SHAREHOLDERS’ EQUITY|
|Other current liabilities||359||409|
|Total current liabilities||4,025||3,912|
|Commitments and contingencies (Note 8)|
|Preferred stock, $.001 par value: authorized 10,000,000 shares:|
|Series B Convertible Preferred stock, (liquidation preference of $5,659,000) stated value $1,000 per share, $.001 par value: 10,000 shares designated and 5,659 issued and outstanding as of September 30, 2013 and December 31, 2012||—||—|
|Common stock, $.001 par value: authorized 200,000,000 shares, issued and outstanding, 23,878,300 shares as of September 30, 2013 and 23,674,541 as of December 31, 2012||24||24|
|Additional paid-in capital||225,560||223,575|
|Treasury stock, 162,066 shares as of September 30, 2013 and 150,000 shares as of December 31, 2012||(499||)||(463||)|
|Total shareholders’ equity||32,214||35,627|
|Total liabilities and shareholders’ equity||$||36,239||$||39,539|
|eMAGIN CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands, except share and per share data) (unaudited)|
|Three Months Ended||Nine Months Ended|
|September 30,||September 30,|
|Total revenue, net||6,329||7,510||21,860||22,234|
|Cost of goods sold:|
|Total cost of goods sold||4,104||3,861||13,493||11,391|
|Research and development||1,239||1,173||3,882||3,571|
|Selling, general and administrative||2,041||1,918||6,358||6,525|
|Total operating expenses||3,280||3,091||10,240||10,096|
|(Loss) income from operations||(1,055||)||558||(1,873||)||747|
|Other income (expense):|
|Interest expense, net||(11||)||(10||)||(32||)||(18||)|
|Other income, net||9||13||45||32|
|Total other income (expense), net||(2||)||3||13||14|
|(Loss) income before provision for income taxes||(1,057||)||561||(1,860||)||761|
|Provision for income taxes||3,502||221||3,502||295|
|Net (loss) income||$||(4,559||)||$||340||$||(5,362||)||$||466|
|Less net income allocated to participating securities||—||83||—||113|
|Net (loss) income allocated to common shares||$||(4,559||)||$||257||$||(5,362||)||$||353|
|(Loss) income per share, basic||$||(0.19||)||$||0.01||$||(0.23||)||$||0.02|
|(Loss) income per share, diluted||$||(0.19||)||$||0.01||$||(0.23||)||$||0.01|
|Weighted average number of shares outstanding:|
|For the Three Months Ended September 30,||For the Nine Months Ended September 30,|
|Net (loss) income||$||(4,559||)||$||340||$||(5,362||)||$||466|
|Adjusted net (loss) income||(4,559||)||333||(5,362||)||413|
|Depreciation and amortization expense||231||57||656||168|
|Provision for income taxes||3,502||221||3,502||295|